glp-1 receptor agonist antipsychotic weight gain study Semaglutide, a second-generation agonist, was associated with significantly reduced body and other metabolic factors in adults with schizophrenia, prediabetes, and overweight/obesity compared with placebo, research from September November Blog - What happens
Description
Allulose consumed with carbohydrate-containing meals may interact with glucose-sensing mechanisms in enteroendocrine cells, potentially enhancing or modifying the incretin response
2) GLP-1 [9]
These studies indicate how agonist-specific endocytosis and recycling influences the surface and total cellular GLP-1R over prolonged exposure times
10.1016/j.jacbts.2021.04.006 178 ShirakawaJ.FujiiH.OhnumaK.SatoK.ItoY.KajiM.et al (2011)
doi: 10.1016/S0024-3205(02)02242-7
